BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 19474340)

  • 1. Efficient silencing of gene expression with modular trimeric Pol II expression cassettes comprising microRNA shuttles.
    Ely A; Naidoo T; Arbuthnot P
    Nucleic Acids Res; 2009 Jul; 37(13):e91. PubMed ID: 19474340
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expressed anti-HBV primary microRNA shuttles inhibit viral replication efficiently in vitro and in vivo.
    Ely A; Naidoo T; Mufamadi S; Crowther C; Arbuthnot P
    Mol Ther; 2008 Jun; 16(6):1105-12. PubMed ID: 18431360
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of hepatitis B virus replication with linear DNA sequences expressing antiviral micro-RNA shuttles.
    Chattopadhyay S; Ely A; Bloom K; Weinberg MS; Arbuthnot P
    Biochem Biophys Res Commun; 2009 Nov; 389(3):484-9. PubMed ID: 19733548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficient silencing of hepatitis B virus by helper-dependent adenovirus vector-mediated delivery of artificial antiviral primary micro RNAs.
    Mowa MB; Crowther C; Ely A; Arbuthnot P
    Microrna; 2012; 1(1):19-25. PubMed ID: 25048086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. tRNA Lys3 promoter cassettes that efficiently express RNAi-activating antihepatitis B virus short hairpin RNAs.
    Dyer V; Ely A; Bloom K; Weinberg M; Arbuthnot P
    Biochem Biophys Res Commun; 2010 Aug; 398(4):640-6. PubMed ID: 20599752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of hepatitis B virus replication by helper dependent adenoviral vectors expressing artificial anti-HBV pri-miRs from a liver-specific promoter.
    Mowa MB; Crowther C; Ely A; Arbuthnot P
    Biomed Res Int; 2014; 2014():718743. PubMed ID: 25003129
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Successful disabling of the 5' UTR of HCV using adeno-associated viral vectors to deliver modular multimeric primary microRNA mimics.
    Bourhill T; Arbuthnot P; Ely A
    J Virol Methods; 2016 Sep; 235():26-33. PubMed ID: 27181212
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effective anti-hepatitis B virus hammerhead ribozymes derived from multimeric precursors.
    Weinberg MS; Ely A; Passman M; Mufamadi SM; Arbuthnot P
    Oligonucleotides; 2007; 17(1):104-12. PubMed ID: 17461767
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sustained inhibition of hepatitis B virus replication in vivo using RNAi-activating lentiviruses.
    Ivacik D; Ely A; Ferry N; Arbuthnot P
    Gene Ther; 2015 Feb; 22(2):163-71. PubMed ID: 25338920
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generating DNA Expression Cassettes Encoding Multimeric Artificial MicroRNA Precursors.
    van den Berg FT; Ely A; Arbuthnot P
    Methods Mol Biol; 2020; 2115():185-197. PubMed ID: 32006402
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sustained Inhibition of HBV Replication In Vivo after Systemic Injection of AAVs Encoding Artificial Antiviral Primary MicroRNAs.
    Maepa MB; Ely A; Grayson W; Arbuthnot P
    Mol Ther Nucleic Acids; 2017 Jun; 7():190-199. PubMed ID: 28624194
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNA polymerase III can drive polycistronic expression of functional interfering RNAs designed to resemble microRNAs.
    Snyder LL; Ahmed I; Steel LF
    Nucleic Acids Res; 2009 Oct; 37(19):e127. PubMed ID: 19679642
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Human miR-5193 Triggers Gene Silencing in Multiple Genotypes of Hepatitis B Virus.
    Khlaiphuengsin A; T-Thienprasert NP; Tangkijvanich P; Posuwan N; Makkoch J; Poovorawan Y; Payungporn S
    Microrna; 2015; 4(2):123-30. PubMed ID: 26456535
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vector design for liver-specific expression of multiple interfering RNAs that target hepatitis B virus transcripts.
    Snyder LL; Esser JM; Pachuk CJ; Steel LF
    Antiviral Res; 2008 Oct; 80(1):36-44. PubMed ID: 18499277
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of HIV-1 replication with designed miRNAs expressed from RNA polymerase II promoters.
    Lo HL; Chang T; Yam P; Marcovecchio PM; Li S; Zaia JA; Yee JK
    Gene Ther; 2007 Nov; 14(21):1503-12. PubMed ID: 17805304
    [TBL] [Abstract][Full Text] [Related]  

  • 16. RNA interference inhibits hepatitis B virus gene expression and replication in HepG2-N10 cells.
    Ren JL; Pan JS; Cheng T; Dong J; Lu YP; Huang SJ; Shi HX; Wang L; Lian YM
    Chin J Dig Dis; 2006; 7(4):230-6. PubMed ID: 17054586
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Endogenous antiviral microRNAs determine permissiveness for hepatitis B virus replication in cultured human fetal and adult hepatocytes.
    Kumar M; Sharma Y; Bandi S; Gupta S
    J Med Virol; 2015 Jul; 87(7):1168-83. PubMed ID: 25690916
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inhibition of HBV replication in vivo using helper-dependent adenovirus vectors to deliver antiviral RNA interference expression cassettes.
    Crowther C; Mowa MB; Ely A; Arbuthnot PB
    Antivir Ther; 2014; 19(4):363-73. PubMed ID: 24296696
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effective inhibition of hepatitis B virus replication by small interfering RNAs expressed from human foamy virus vectors.
    Sun Y; Li Z; Li L; Li J; Liu X; Li W
    Int J Mol Med; 2007 Apr; 19(4):705-11. PubMed ID: 17334648
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effective inhibition of HBV replication in vivo by anti-HBx short hairpin RNAs.
    Carmona S; Ely A; Crowther C; Moolla N; Salazar FH; Marion PL; Ferry N; Weinberg MS; Arbuthnot P
    Mol Ther; 2006 Feb; 13(2):411-21. PubMed ID: 16337206
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.